SO017BIOINFORMATICS-BASED IDENTIFICATION OF URINARY KIDNEY-SPECIFIC MRNAS AS POTENTIAL BIOMARKERS OF DIABETIC KIDNEY DISEASE

Le-Ting Zhou,Lin-Li Lv,Qing Yin,Tao-Tao Tang,Yi Wen,Bi-Cheng Liu
DOI: https://doi.org/10.1093/ndt/gfx102.so017
IF: 7.1857
2017-01-01
Nephrology Dialysis Transplantation
Abstract:with improvement indicate basically less inflammation and renal and/or tubular dam- age present at baseline. Hence, our multi-marker panel approach may be implemented into the routine clinical practice and management of advanced CKD stages, accepting that an improved eGFR may be a possible outcome. features of DKD were selected as candidate biomarkers. A self-assembling PCR array consisting of mRNAs with largest fold changes(FC) was constructed for further evalua-tion. 9 randomly-selected urinary mRNA samples of DKD patients were used to test the basic performance of the PCR array. RESULTS: A total of 108 qualified microarray datasets were included in the final analysis. Thirty-five mRNAs with largest FC, including ALDOB(logFC:8.86,P=1.62E-26,compared with bladder epithelia) and CCL18(logFC:4.31,P=3.42E-7, compared with bladder epithelia), were identified, most of which haven’t been reported as biomarkers of DKD. The PCR array system achieved a positive call rate > 85% with all 9 samples. Melting curve analysis showed that single peak could be obtained for each reaction. The threshold cycle value of positive PCR control for eachsample indicated good reproducibility of the PCR array. CONCLUSIONS: Our study provided a novel methodology to identify and analyze urinary kidney-specific mRNAs in DKD, which could also be applied to other kidney diseases. Using the self-assembling PCR array, our future study will fur- ther validate the performance of the selected urinary mRNAs in monitoring DKD progression.
What problem does this paper attempt to address?